Launch of “AQUALA,” an Aquaculture Feed

09/02/2019

New Release of “Aquala”, a Mixed Feed for Aquaculture

NeoPharma Japan Co., Ltd. (Headquarters: Tokyo, CEO: Satoshi Kawada, hereinafter “NeoPharma Japan”) and MSD Animal Health Co., Ltd. (Headquarters: Tokyo) are pleased to announce the launch of the newly developed and manufactured aquaculture mixed feed “Aquala” today (September 2, 2019).

“Aquala” is a natural mixed feed containing 5-ALA (5-Aminolevulinic Acid), an essential substance in the mitochondria where most of the body’s energy is produced. By selling “Aquala” containing 5-ALA, both companies aim to contribute to the productivity improvement of the aquaculture industry.

Product Release: Aquala

Main Ingredient: 5-ALA (5-Aminolevulinic Acid)

Release Date: September 2, 2019 (Monday)

Expected Benefits: 1. Growth promotion 2. Improvement of feed conversion ratio 3. Increase in red blood cells (reduction of low oxygen stress)

Manufacturer and Seller: NeoPharma Japan Co., Ltd.

Distributor: MSD Animal Health Co., Ltd.

September 2, 2019News

Are you interested in
KIYAN PHARMA’s business?

Are you interested in
KIYAN PHARMA’s business?

Healthcare and medical professionals, investors, and members of the press are welcome to contact us via the email form with the necessary information. Our representatives will get back to you.